Survodutide: Still in clinical trials, survodutide follows the same general peptide storage principles
Start your intake How Long Most People Stay on GLP-1 Treatment Research indicates that individuals on GLP-1 therapy typically continue treatment for at least 6 to 12 months to see meaningful weight loss results, with many remaining on medications for 18 months or longer
With proper support and dosing adjustments, these effects usually resolve
Clinical studies, such as the STEP trials for semaglutide, show that sustained use leads to greater weight loss and better maintenance of results
For immediate wellness support, explore our GLP-1 Daily Support and Weight Loss Boost
Frequency: Once to twice weekly for maintenance, or more frequently during deficiency correction